SMARCA4 and Hypertension: Rs1122608 in SMARCA4 was also significantly associated with a decreased risk of hypertension in the dominant model (OR = 0.61; 95% CI = 0.38–0.99, p = .047 for the “G/T‐T/T” genotype) and log‐additive model (OR = 0.61; 95% CI = 0.38–0.98, p = .038), respectively.